Cigna Stock News

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.

Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.

Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients ST LOUIS , May 21, 2025  /PRNewswire/ -- Evernorth, the health services div...

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively, and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth qu...

The abrupt departure of UnitedHealth (NYSE:UNH) CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector.

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Monday wasn't a very good day for health insurers, and if a day's not good for health insurers you can bet Cigna Group (CI -5.49%) stock took it on the chin.